| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cells. | J Immunol | 2009 | 1.56 |
| 2 | Impact of bacteria on the phenotype, functions, and therapeutic activities of invariant NKT cells in mice. | J Clin Invest | 2008 | 1.19 |
| 3 | Thymus leukemia antigen controls intraepithelial lymphocyte function and inflammatory bowel disease. | Proc Natl Acad Sci U S A | 2008 | 1.14 |
| 4 | c-Maf interacts with c-Myb to down-regulate Bcl-2 expression and increase apoptosis in peripheral CD4 cells. | Eur J Immunol | 2007 | 0.96 |
| 5 | The in vivo response of invariant natural killer T cells to glycolipid antigens. | Int Rev Immunol | 2007 | 0.88 |
| 6 | Glycolipid ligands of invariant natural killer T cells as vaccine adjuvants. | Expert Rev Vaccines | 2008 | 0.86 |